Header Logo

Connection

Edward Kelly to Drug Interactions

This is a "connection" page, showing publications Edward Kelly has written about Drug Interactions.
Connection Strength

0.535
  1. Hsu EW, Wang K, Tsang YP, Himmelfarb J, Yeung CK, Kelly EJ. Potential integration of multiple organs-on-a-chip for comprehensive drug-drug interaction prediction. Expert Opin Drug Metab Toxicol. 2026 Jan-Feb; 22(2):83-103.
    View in: PubMed
    Score: 0.231
  2. O'Mahony ET, Arian CM, Aryeh KS, Wang K, Thummel KE, Kelly EJ. Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy. Pharmacol Ther. 2025 09; 273:108879.
    View in: PubMed
    Score: 0.220
  3. Arian CM, O'Mahony ET, Manwill PK, Graf TN, Oberlies NH, Cech NB, Clarke JD, Smith JG, Paine MF, Kelly EJ, Thummel KE. A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption. J Pharmacol Exp Ther. 2025 Jun; 392(6):103597.
    View in: PubMed
    Score: 0.055
  4. Farooq M, Kelly EJ, Unadkat JD. CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids. Drug Metab Dispos. 2016 May; 44(5):750-7.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.